![Michael Bolinder](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Bolinder
Directeur Général chez ACACIA PHARMA GROUP PLC
Postes actifs de Michael Bolinder
Sociétés | Poste | Début | Fin |
---|---|---|---|
ACACIA PHARMA GROUP PLC | Directeur Général | 01/08/2019 | - |
Historique de carrière de Michael Bolinder
Anciens postes connus de Michael Bolinder
Sociétés | Poste | Début | Fin |
---|---|---|---|
Mallinckrodt Pharmaceuticals Ltd.
![]() Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015. | Sales & Marketing | 01/09/2013 | 01/08/2015 |
Formation de Michael Bolinder
Florida State University | Undergraduate Degree |
Statistiques
Internationale
Royaume-Uni | 3 |
Etats-Unis | 2 |
Opérationnelle
Chief Executive Officer | 1 |
Undergraduate Degree | 1 |
Sales & Marketing | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Acacia Pharma Group Ltd.
![]() Acacia Pharma Group Ltd. Pharmaceuticals: OtherHealth Technology Acacia Pharma Group Plc is a holding company, which engages in the development and commercialization of pharmaceutical product. It focuses on the new nausea and vomiting treatments for surgical and cancer patients. The company was founded by Julian Clive Gilbert, Robert William Gristwood, and Andrew Muncey in 2007 and is headquartered in Duxford, the United Kingdom. | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
![]() Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015. | Health Technology |
- Bourse
- Insiders
- Michael Bolinder
- Expérience